Back to search
FDAFDA · Food and drugs·Recall number D-0287-2019

Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1

Published December 5, 2018 · Recall initiated: November 14, 2018

Summary

FDA records drug Class II recall D-0287-2019, published December 5, 2018 and initiated November 14, 2018. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: N/A; Lot: Lot 7143908, exp Nov 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Substance; metal shard found in tablet

What to do

Voluntary: Firm initiated · Letter

Get an email if QUETIAPINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
QUETIAPINE
Manufacturer
Ascend Laboratories LLC
Distributor
Nationwide
UPC
367877248011
Lot
Lot 7143908, exp Nov 2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India. Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 --- NDC 67877-248-01, UPC code: 3 67877-248-01 1 recalled?

Yes. FDA published recall D-0287-2019 on December 5, 2018. Reported hazard: Presence of Foreign Substance; metal shard found in tablet

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: QUETIAPINE. UPC: 367877248011.